1. Ad Hoc Group for the Study of Pertussis Vaccines. (1988). Placebo-controlled trial of two acellular pertussis vaccines in Sweden—Protective efficacy and adverse events. Lancet 1: 955–960.
2. Amara, R.R., and Robinson, H.L. (2002). A new generation of HIV vaccines. Trends Mol Med. 8: 489–495.
3. Baylor, N.W., and Midthun, K. (2004). Regulation and testing of vaccines. In: Plotkin, S.A., and Orenstein, W.A. (eds.), Vaccines, 4th ed. W.B. Saunders, Philadelphia, pp. 1539–1556.
4. Belshe, R.B., Bolognesi, D.P., Clements, M.L., Corey, L., Dolin, R., Mestecky, J., Stablein, D., and Wright, P. (1994). HIV infection in vaccinated volunteers. JAMA 272: 431. [Letter]
5. Berman, P.W., Gray, A.M., Wrin, T., Vennari, J.C., Eastman, D.J., Nakamura, G.R., Francis, D.P., Gorse, G., and Schwartz, D.H. (1997). Genetic and immunologic characterization of viruses infecting MN-rgp120-vaccinated volunteers. J Infect Dis. 176: 384–397.